Huaiqi huang Granules combined with dexamethasone in the treatment of adult primary immune thrombocytopenia: a single center, randomized, controlled and open trial

Phase 4

Recruiting

• Conditions: Adult newly diagnosed ITP

• Registration Number: ITMCTR2100004313
• Lead Sponsor: The First Affiliated Hospital of Dalian Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the diagnostic criteria of adult primary ITP(PLT < 30 x 10^9/L).
2. Aged 18~70 years.
3. No serious heart, lung, liver, kidney and other functional diseases, no infection, diabetes, rheumatism, tumor, etc.
4. No history of special drugs such as glucocorticoid, immunosuppressant and traditional Chinese medicine within two weeksbefore entering the group.
5. Patients who are willing to receive treatment and sign an informed consent form.

Exclusion Criteria

1. Women during pregnancy and lactation.
2. Combined with serious heart, lung, liver, kidney diseases and malignant tumors, diabetes, mental illness,etc.
3. Not suitable to use .
4. Serious or uncontrolled infection.
5. Received special drugs such as glucocorticoid, immunosuppressant and traditional Chinese medicine within two weeks before entering the group.
6. Cannot follow up as scheduled.
7. The researcher believes that it is not suitable for enrollment.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood routine;lymphocyte subsets;